EP3571193
Kalíumgangastillar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.1.2018EP published:
1.12.2021EP application number:
18704122.3
EP translation filed:
18.1.2022Grant published:
15.2.2022EPO information:
European Patent Register
Max expiry date:
22.1.2038Expiry date:
22.1.2027Next due date:
31.1.2027
Title in English:
POTASSIUM CHANNEL MODULATORSLanguage of the patent:
English
Timeline
Today
23.1.2018EP application
1.12.2021EP Publication
18.1.2022Translation submitted
15.2.2022Registration published
22.1.2027Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
AMRUTKAR, Dipak, VasantraoAddress:
DK-2750 Ballerup, DK
Name:
FOSTER, KellyAddress:
Watertown MA 02139, US
Name:
JACOBSEN, Thomas, AmosAddress:
DK-3310 Oested, DK
Name:
JEFSON, Martin, R.Address:
Stonington CT 06378, US
Name:
KEANEY, Gregg, F.Address:
Lexington MA 02421, US
Name:
LARSEN, Janus, SchreiberAddress:
DK-4300 Holbaek, DK
Name:
NIELSEN, Karin, SandagerAddress:
DK-3480 Fredensborg, DK
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762449270 PDate:
23.1.2017Country:
US
Classification
Categories:
C07D 403/04, C07D 417/04, A61P 25/30, A61K 31/506
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 14.1.2022
Expires: 22.1.2023
Payer: Árnason Faktor ehf.
Number: 6
Paid: 22.12.2022
Expires: 22.1.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 27.12.2023
Expires: 22.1.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 13.1.2025
Expires: 22.1.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 13.1.2026
Expires: 22.1.2027
Payer: Árnason Faktor ehf.